Latest Plavix news
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
posted June 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Generic Clopidogrel Noninferior to Plavix in Seniors With ACS
posted March 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients aged older than 65 years with an acute coronary syndrome (ACS) hospitalization, generic clopidogrel is noninferior to Plavix for the composite of death and recurrent hospitalization for ACS, according to a study published online March 13 in Circulation: Cardiovascular Quality and Outcomes.
AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD
posted November 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Ticagrelor is not superior to clopidogrel for reduction of cardiovascular events in patients with peripheral artery disease, according to a study published online Nov. 13 in the New England Journal of Medicine to coincide with the annual meeting of the American Heart Association, held from Nov. 12 to 16 in New Orleans.
Editor's Recommendations
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Adverse Pregnancy Outcomes Linked to Increased Risk for Peripheral Artery Disease 
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes 
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism Related Articles
.jpg)
Guideline Updated for Early Management of Acute Ischemic Stroke 
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE 
Risks for Vascular, Inflammatory Diseases Increased for Children After COVID-19 Monthly Specialist Briefings
Stay Connected
